Aims The objective of the study was to investigate the influence of a history of arterial hypertension on longterm prognosis after an acute myocardial infarction in a representative population, and secondly to assess the impact on prognosis of left ventricular systolic function in hypertensives after acute myocardial infarction.
Introduction
Arterial hypertension is a well-known risk factor for the development of ischaemic heart disease [1, 2] and approximately one-third of patients admitted to hospital with an acute myocardial infarction has a history of hypertension [3, 4] . In recent decades, the impact of a history of elevated blood pressure on prognosis in survivors of a myocardial infarction has been evaluated in several studies. The results of these investigations are conflicting. Furthermore, the studies were either conducted in the pre-thrombolytic era [3] [4] [5] [6] [7] [8] [9] [10] or only describe patients eligible for thrombolytic treatment [11] , and thus it is unclear whether the results are applicable to a current, unselected population with acute myocardial infarction.
Little is known of the influence of left ventricular systolic function on prognosis in hypertensives with acute myocardial infarction, even though this parameter is known to be among the most important prognostic variables after a myocardial infarction in general [12, 13] . The aim of the present study was to evaluate the importance of a history of hypertension on longterm prognosis after acute myocardial infarction in a representative population using data from the TRACE register, and secondly to assess the influence of post-infarction left ventricular systolic function on the prognosis of this particular group of patients.
Methods

Patients
Consecutive patients admitted alive to 27 Danish coronary care units were included in the study. They comprise the TRACE (TRAndolapril Cardiac Evaluation) register of patients screened for entry into the TRACE study, which was a randomized, placebocontrolled, double-blind trial of the efficacy of the angiotensin converting enzyme inhibitor trandolapril in patients with acute myocardial infarction and left ventricular systolic dysfunction. The main end-point was total mortality. Details of the study design and results have been described elsewhere [14, 15] . A total of 7001 infarctions in 6676 patients were included from May 1990 to July 1992. Some patients who were not included in the clinical trial were re-screened if admitted with a new myocardial infarction in the inclusion period. In the statistical analyses of the present study the patients were only included once (at the time of the first infarction). For all patients, medical history and in-hospital events were recorded. A two-dimensional echocardiographic examination was recorded on videotape 2-6 days after the infarction.
Acute myocardial infarction was defined as chest discomfort accompanied by elevation of cardiac enzymes to at least twice the upper normal value. Specific electrocardiographic changes were not required. A history of hypertension was considered to be present when a clinical diagnosis had resulted in pharmacological therapy prior to the infarction. This definition was preferred to avoid classification of patients as hypertensives merely on the basis of patient's recall of results of previous blood pressure measurements. Previous blood pressure measurements are not available in the hospital records in most cases since the diagnosis of arterial hypertension is often made in general practice. The definition of pre-existing heart failure, angina pectoris and diabetes relied on information obtained from the patient or the hospital records. In the case of heart failure and angina pectoris it was required that the patient was or had been treated pharmacologically for the condition. Newly developed heart failure was considered present when anti-congestive treatment was instituted in a patient not previously treated for heart failure.
Echocardiography
The videotaped echocardiograms were subsequently analysed by one of two members of the study group. Left ventricular systolic function was evaluated by estimation of wall motion index. This method has been described and validated previously [16] . A normal systolic function corresponds to a wall motion index of at least 2·0. An ejection fraction of 35% is approximately equivalent to a wall motion index of 1·2. A wall motion index below this value was defined as left ventricular dysfunction.
Mortality data
Information on survival status was obtained from the Danish central personal registry. In Denmark all residents are given a central personal registry number and all deaths are registered with this number within 2 weeks. Survival status on the screened subjects was acquired by a computerized search on 10 October 1996. Survival information was available on 6673 patients. Survival data on three patients were missing due to erroneous recording of registry number at screening. Twenty-eight non-Danish residents, who are not recorded in the personal registry, were censored at the time of hospital discharge.
Ethics
The study was approved by all local ethics committees in Denmark.
Statistics
Baseline characteristics were compared using the chi-square test for discrete variables and the Wilcoxon rank sum test for continuous variables. Mortality curves were generated by means of Kaplan-Meier estimates. Relative risks and 95% confidence intervals were calculated as hazard ratios derived from the Cox proportional hazard regression model. Analysis of interaction was studied using a likelihood ratio test in a multivariate model containing the variables listed in Table 2 . A P value <0·05 was considered significant. All calculations were generated by the Statistical Analysis System (SAS Institute, Cary, NC, U.S.A.).
Results
A history of arterial hypertension was found in 1507 (23%) patients. The diagnosis had been made 7 (0-51) (median with range) years prior to the myocardial infarction. Information on hypertension history was missing in 13 patients. Baseline characteristics of patients with and without a history of hypertension are presented in Table 1 . In hypertensives, who were slightly older than normotensives, previous infarction, angina pectoris and diabetes were more common. In normotensives, male gender and smoking were more common. On admission, normotensives more frequently presented with ST-segment elevations on the electrocardiogram and thrombolysis and aspirin were administered more frequently in this group. The prevalence of pre-existing heart failure, atrial fibrillation, and anterior Q-wave infarction did not differ significantly in the two groups. No differences in left ventricular systolic function or ventricular fibrillation after the myocardial infarction were found. More hypertensives developed heart failure after the infarction (P=0·06). Hypertensives were predominantly treated with diuretics (59%) prior to the myocardial infarction. Some of the normotensives were treated with beta-blockers, calcium antagonists and angiotensin converting enzyme inhibitors mainly due to pre-existing heart failure or angina pectoris.
Mortality
Six days after the infarction 88 (6%) hypertensives and 297 (6%) normotensives had died and thus there was no difference in mortality during this period (P=0·64). Accordingly, in a multivariate analysis considering 12 potential predictors of mortality after myocardial infarction (listed in Table 2 ), the mortality risk associated with hypertension after 6 days was 0·96 (0·68-1·36).
During the entire period of observation, 763 (50·6%) hypertensives and 2253 (43·7%) normotensives died, corresponding to a risk ratio for hypertensives of 1·23 (1·13-1·33) (univariate analysis, P<0·0001). Mortality curves are shown in Fig. 1 . In a multivariate analysis, the risk ratio for death of patients with a history of hypertension remained significantly increased when compared to normotensive individuals (risk ratio 1·14 (1·04-1·24), P=0·006) ( Table 2) . Apart from hypertension history, increasing age, atrial fibrillation, chronic heart failure, angina pectoris, diabetes, low wall motion index and ventricular fibrillation emerged as independent risk factors, with low wall motion index and heart failure being the strongest predictors. Thrombolysis was associated with a lower mortality (risk ratio 0·68 (0·62-0·74), P<0·001). Test of interaction between hypertension and all covariates was performed, but only age interacted significantly with hypertension (P<0·001), as illustrated in Fig. 2 . A history of hypertension increased mortality significantly in younger patients (c65 years, risk ratio 1·44 (1·20-1·72), P<0·0001 (multivariate analysis)), whereas this effect was not detectable in patients aged more than 65 years (risk ratio 1·00 (0·90-1·10), P=0·99). This excess risk in younger hypertensives was similar in women and men (RR=1·38 (0·96-1·99) and RR=1·41 (1·14-1·75), respectively). Hypertension was associated with an increased mortality independently of left ventricular systolic function as shown in Fig. 3 .
Discussion
This study demonstrates that a history of hypertension in patients with acute myocardial infarction is a risk factor for future mortality even after controlling for the influence of several potential confounders. The study also demonstrates an important interaction with age. Hypertension is a risk factor among younger patients (risk ratio 1·4 in patients younger than 65), but not among older (risk ratio 1·0). The proportion of hypertensives in the present study population (23%) was comparable to that reported by others [3, 4, [17] [18] [19] [20] . The two groups differed considerably with regards to risk factors at baseline according to results of previous studies [4, 11] . Very importantly, however, the presence of impaired left ventricular systolic function did not differ significantly in the two groups. There was a trend towards a higher frequency of clinical heart failure after the infarction in hypertensives despite identical wall motion indices in the two groups. This difference might be attributable to a larger prevalence of left ventricular diastolic dysfunction in the hypertensives.
The present analysis is the first large study of the importance of hypertension on prognosis in an unselected population of survivors of a myocardial infarction to be conducted in the thrombolytic era. The findings are in accordance with a study of patients 
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selected for thrombolytic therapy [11] and a number of studies performed before thrombolytic therapy was introduced [3, 5, [7] [8] [9] 18, 19] . In a study by Herlitz et al. comprising 862 patients with acute myocardial infarction mortality was 18% higher in patients with a history of hypertension, but this difference was not significant in a multivariate analysis [6] . The discrepancy between this finding and that of other studies could be explained by the interaction with age we have demonstrated. Hence, in the Swedish study there was a steady decline in relative risk with age, and since the majority of deaths were observed in patients over 75 years of age, it could be speculated that the number of younger patients (and thereby the number of events) was too small to detect a statistically significant difference in overall mortality in hypertensives.
Interaction between a history of arterial hypertension and age on the prognosis after acute myocardial infarction has not previously been described directly. The only other study, which has formally examined an interaction, is the GISSI-2 study in which no interaction was observed. This study is, however, not representative of a general population with myocardial infarction as the patients were required to qualify for and accept participation in the GISSI-2 study [17] . Several possible explanations for the excess mortality in hypertensives exist. Firstly, it could be speculated that the hypertensives might have more extensive coronary artery disease than the normotensive subjects [21] . Also, it is likely that left ventricular hypertrophy was more frequently present in the hypertensives. Left ventricular hypertrophy may lead to impaired coronary reserve and myocardial ischaemia even in the presence of normal coronary arteries [22, 23] and left ventricular hypertrophy is a well-established independent predictor of mortality [24, 25] . Thus, it is possible that an over-representation of left ventricular hypertrophy in the hypertensive group is responsible for the excess mortality in this group. It is well documented that hypertensives with left ventricular hypertrophy carry an excess risk of sudden death in particular and therefore information on the occurrence of sudden death is likely to add important data to future studies [26] . In the present investigation it was found that thrombolysis was administered more frequently to normotensives than to hypertensives. This may be due to a higher age or a perceived higher risk of bleeding complications, but it could also result from the fact that hypertensives with acute myocardial infarction less frequently had ST elevation in the electrocardiogram on admission, and thus did not meet standard criteria for thrombolysis. However, even if less hypertensives had effective reperfusion, this factor cannot explain the excess mortality of the group, since thrombolysis and left ventricular systolic function were included as covariates in the multivariate analysis.
It could be speculated that the adverse prognosis in hypertensives with acute myocardial infarction could be attributed to a greater risk of infarct expansion and remodelling, a process which clearly indicates a poor prognosis. A higher incidence of infarct expansion in hypertensives has been reported by some authors [27] . However, infarct expansion most commonly complicates large anterior transmural infarction [28] . In the present study, the prevalence of anterior Q-wave infarcts and left ventricular systolic function were comparable in the two groups, and thus a higher incidence of infarct expansion is unlikely to be responsible for the difference in mortality.
Finally, it is possible that non-cardiac complications, for example stroke, may explain the excess mortality in hypertensives. Although highly interesting, this hypothesis cannot be tested in the present study since information on the cause of death is not available in the database.
We do not have data that can explain the interaction between age and risk associated with hypertension. A possible reason for the interaction could be that the excess mortality associated with hypertension disappears in the increasing mortality generally observed with advancing age. In comparison, however, it should be noted that in the present study a difference in mortality between hypertensives and normotensives exists even in patients with severe reduction in left ventricular systolic function, who have an average 5-year mortality of approximately 70% (Fig. 3) . Thus, in this group, even a very high mortality does not dilute the deleterious effect of hypertension on prognosis. Another theoretical explanation of the interaction between age and hypertension could be that the patients included in the study were all treated with anti-hypertensive medications. It is well known that anti-hypertensive treatment in older patients more effectively reduces cardiovascular mortality than is the case in younger patients [29, 30] . Thus, it could be speculated that the lack of difference in mortality in older patients in the present study is a result of effective anti-hypertensive therapy. However, further studies are needed to investigate the relationship between age and the influence of hypertension on prognosis after myocardial infarction.
In conclusion, a history of hypertension in patients admitted alive with acute myocardial infarction is associated with a moderately increased long-term mortality. The excess risk is observed in patients below 65 years of age and disappears in older patients.
The TRACE study was sponsored by Knoll AG and Roussel Uclaf.
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